Loss of ARID1A ‘loops’ in STING
Trends in Immunology · 2024
DOI: 10.1016/j.it.2024.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Immunology, 2024. Verfasst von Sangeeta Goswami und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The Univ…. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, Neoplasms, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
In a recent article, Maxwell et al. report that loss of tumor cell-specific AT-rich interaction domain 1A (ARID1A), a component of the chromatin remodeling SWI/SNF complex, triggers antitumor immunity via R-loop-mediated upregulation of the type-I interferon (IFN) pathway. These recent findings uncover a molecular mechanism underlying improved responses to immune checkpoint therapy (ICT) seen in patients harboring an ARID1A loss-of-function mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; James P.…
Zitieren
APA
Goswami, S., & Sharma, P. (2024). Loss of ARID1A ‘loops’ in STING. Trends in Immunology. https://doi.org/10.1016/j.it.2024.07.001
Vancouver
Goswami S, Sharma P. Loss of ARID1A ‘loops’ in STING. Trends in Immunology. 2024. doi:10.1016/j.it.2024.07.001
BibTeX
@article{Goswami2024,
author = {Goswami, Sangeeta and Sharma, Padmanee},
title = {Loss of ARID1A ‘loops’ in STING},
journal = {Trends in Immunology},
year = {2024},
doi = {10.1016/j.it.2024.07.001}
}
EUVIMED